Kansas City, MO4 Active Studies

Parkinsons Disease Clinical Trials in Kansas City, MO

Find 4 actively recruiting parkinsons disease clinical trials in Kansas City, MO. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
444
Enrolling

Recruiting Parkinsons Disease Studies in Kansas City

About Parkinsons Disease Clinical Trials in Kansas City

Parkinson's disease is a progressive nervous system disorder that affects movement, causing tremors, stiffness, and difficulty with balance. It results from the loss of dopamine-producing neurons in the brain. Treatment includes medications, deep brain stimulation, and emerging therapies targeting disease modification.

There are currently 4 parkinsons disease clinical trials recruiting participants in Kansas City, MO. These studies are seeking a combined 444 participants. Research is being sponsored by Connect Biopharm LLC, Merck Sharp & Dohme LLC, BlueRock Therapeutics and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Parkinsons Disease Clinical Trials in Kansas City — FAQ

Are there parkinsons disease clinical trials in Kansas City?

Yes, there are 4 parkinsons disease clinical trials currently recruiting in Kansas City, MO. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Kansas City?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Kansas City research site will contact you about next steps.

Are clinical trials in Kansas City free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Kansas City studies also compensate for your time and travel.

What parkinsons disease treatments are being tested?

The 4 active trials in Kansas City are testing new therapies including novel drugs, biologics, and treatment approaches for parkinsons disease.

Data updated March 2, 2026 from ClinicalTrials.gov